Literature DB >> 19380334

Molecular dynamics studies on the interactions of PTP1B with inhibitors: from the first phosphate-binding site to the second one.

Jing-Fang Wang1, Ke Gong, Dong-Qing Wei, Yi-Xue Li, Kuo-Chen Chou.   

Abstract

Protein tyrosine phosphatases 1B (PTP1B) is a major negative regulator of both insulin and leptin signaling pathways. In view of this, it becomes an important target for drug development against cancers, diabetes and obesity. The aim of the current study is to use the long time-scale molecular dynamics (MD) simulations to investigate the structural and dynamic factors that cause its inhibition by INTA and INTB, the two most potent and highly selective PTP1B inhibitors known so far. In order to investigate the mode of collective motions that is vitally important to the biological function, the covariance matrix of C(alpha) atoms was introduced for performing the dynamic analysis of the inhibition systems. It has been observed that the conformational and dynamic features of WPD-Loop, R-Loop and S-Loop play a key role in providing a smooth entrance for the inhibitors moving into the binding pocket as well as a favorable microenvironment to stabilize them. Furthermore, the hydrogen bonding networks formed around the active site with INTA and INTB may be the main reason of why the inhibition of PTP1B by the two ligands is so potent and selective. All these findings might provide useful insights for developing novel and effective drugs to treat cancer, diabetes and obesity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19380334     DOI: 10.1093/protein/gzp012

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  19 in total

1.  In vitro transcriptomic prediction of hepatotoxicity for early drug discovery.

Authors:  Feng Cheng; Dan Theodorescu; Ira G Schulman; Jae K Lee
Journal:  J Theor Biol       Date:  2011-08-27       Impact factor: 2.691

2.  Modelling the molecular mechanism of protein-protein interactions and their inhibition: CypD-p53 case study.

Authors:  S M Fayaz; G K Rajanikant
Journal:  Mol Divers       Date:  2015-07-14       Impact factor: 2.943

3.  DAKB-GPCRs: An Integrated Computational Platform for Drug Abuse Related GPCRs.

Authors:  Maozi Chen; Yankang Jing; Lirong Wang; Zhiwei Feng; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2019-03-14       Impact factor: 4.956

4.  Exploration of conformational transition in the aryl-binding site of human FXa using molecular dynamics simulations.

Authors:  Jing-Fang Wang; Pei Hao; Yi-Xue Li; Jian-Liang Dai; Xuan Li
Journal:  J Mol Model       Date:  2011-11-25       Impact factor: 1.810

5.  Structural insights of dipeptidyl peptidase-IV inhibitors through molecular dynamics-guided receptor-dependent 4D-QSAR studies.

Authors:  Rajesh B Patil; Euzebio G Barbosa; Jaiprakash N Sangshetti; Vishal P Zambre; Sanjay D Sawant
Journal:  Mol Divers       Date:  2018-03-13       Impact factor: 2.943

6.  Potential entry inhibitors of the envelope protein (E2) of Chikungunya virus: in silico structural modeling, docking and molecular dynamic studies.

Authors:  Farah Deeba; Md Zubbair Malik; Irshad Husain Naqvi; Md Shakir Hussain Haider; Zoya Shafat; Priyanka Sinha; Romana Ishrat; Anwar Ahmed; Shama Parveen
Journal:  Virusdisease       Date:  2017-02-09

7.  Analysis and prediction of the metabolic stability of proteins based on their sequential features, subcellular locations and interaction networks.

Authors:  Tao Huang; Xiao-He Shi; Ping Wang; Zhisong He; Kai-Yan Feng; Lele Hu; Xiangyin Kong; Yi-Xue Li; Yu-Dong Cai; Kuo-Chen Chou
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

8.  Insights from modeling the 3D structure of New Delhi metallo-β-lactamse and its binding interactions with antibiotic drugs.

Authors:  Jing-Fang Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240

9.  Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine.

Authors:  Su-Sen Chang; Hung-Jin Huang; Calvin Yu-Chian Chen
Journal:  PLoS Comput Biol       Date:  2011-12-22       Impact factor: 4.475

10.  Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics.

Authors:  Lei Liu; Ying Ma; Run-Ling Wang; Wei-Ren Xu; Shu-Qing Wang; Kuo-Chen Chou
Journal:  Drug Des Devel Ther       Date:  2013-04-08       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.